In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase

Bioorganic & Medicinal Chemistry Letters
2012.0

Abstract

The human Myt1 kinase (PKMYT1) is an important regulator of the G2/M transition in the cell cycle. Presently, limited knowledge about its substrate recognition is available. Here, various potential substrates were investigated by different antibody based techniques including fluorescence polarization immunoassays and immunoblotting. Regarding both Thr and Tyr kinase activity, only protein substrates were found to be phosphorylated by Myt1, whereas any tested peptide was not recognized. In silico molecular dynamics studies were used to compare the stability of the Myt1 peptide complex with Wee1 peptide complex and support the biochemical findings. Furthermore, a Myt1 kinase binding assay suggests Myt1 being insensitive to staurosporine.

Knowledge Graph

Similar Paper

In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase
Bioorganic & Medicinal Chemistry Letters 2012.0
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay
European Journal of Medicinal Chemistry 2013.0
Identification of Peptide Substrate and Small Molecule Inhibitors of Testis-Specific Serine/Threonine Kinase1 (TSSK1) By the Developed Assays
Journal of Medicinal Chemistry 2009.0
A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). I. Taxonomy and biological activity.
The Journal of Antibiotics 1992.0
A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). I. Taxonomy and biological activity.
The Journal of Antibiotics 1992.0
Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective
Journal of Medicinal Chemistry 2023.0
CD45 protein tyrosine phosphatase: Determination of minimal peptide length for substrate recognition and synthesis of some tyrosine-based electrophiles as potential active-site directed irreversible inhibitors
Bioorganic & Medicinal Chemistry Letters 1995.0
Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure
Bioorganic & Medicinal Chemistry Letters 1998.0
Structural basis for the inhibitor recognition of human Lyn kinase domain
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors
Journal of Medicinal Chemistry 2014.0